Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SHUFENG ZHOU")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Overexpression of phytoene synthase gene from Salicornia europaea alters response to reactive oxygen species under salt stress in transgenic ArabidopsisHEPING HAN; YINXIN LI; SHUFENG ZHOU et al.Biotechnology letters. 2008, Vol 30, Num 8, pp 1501-1507, issn 0141-5492, 7 p.Article

A comparison of glutathione S-transferase mutant frequencies in healthy Han and Uygur ChineseZHONG, Shi-Long; SHUFENG ZHOU; MIN HUANG et al.European journal of drug metabolism and pharmacokinetics. 2005, Vol 30, Num 3, pp 181-185, issn 0378-7966, 5 p.Article

An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters : Experience in SingaporeCHOWBAY, Balram; SHUFENG ZHOU; LEE, Edmund J. D et al.Drug metabolism reviews (Softcover ed.). 2005, Vol 37, Num 2, pp 327-378, issn 0360-2532, 52 p.Article

Non-specific binding of the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in liver microsomes from various speciesSHUFENG ZHOU; KESTELL, Philip; PAXTON, James W et al.Journal of pharmacy and pharmacology. 2002, Vol 54, Num 7, pp 997-1003, issn 0022-3573Article

Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: The experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugationSHUFENG ZHOU; KESTELL, Philip; PAXTON, James W et al.Drug metabolism reviews (Softcover ed.). 2002, Vol 34, Num 4, pp 751-790, issn 0360-2532, 40 p.Article

Strain differences in the liver microsomal metabolism of the experimental anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in miceSHUFENG ZHOU; KESTELL, Philip; PAXTON, James W et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 776, Num 2, pp 231-236, issn 1387-2273, 6 p.Article

Herbal modulation of P-glycoproteinSHUFENG ZHOU; LEE YONG LIM; CHOWBAY, Balram et al.Drug metabolism reviews (Softcover ed.). 2004, Vol 36, Num 1, pp 57-104, issn 0360-2532, 48 p.Article

5,6-dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapySHUFENG ZHOU; KESTELL, Philip; BAGULEY, Bruce C et al.Investigational new drugs. 2002, Vol 20, Num 3, pp 281-295, issn 0167-6997Article

Multidrug resistance proteins (MRPs) and implication in drug developmentQUAN TIAN; JING ZHANG; CHAN, Eli et al.Drug development research. 2005, Vol 64, Num 1, pp 1-18, issn 0272-4391, 18 p.Article

Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acidSHUFENG ZHOU; KESTELL, Philip; BAGULEY, Bruce C et al.Biochemical pharmacology. 2003, Vol 65, Num 11, pp 1853-1865, issn 0006-2952, 13 p.Article

Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acidSHUFENG ZHOU; PAXTON, James W; TINGLE, Malcolm D et al.Drug metabolism and disposition. 2000, Vol 28, Num 12, pp 1449-1456, issn 0090-9556Article

Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various speciesSHUFENG ZHOU; PAXTON, James W; KESTELL, Philip et al.Journal of pharmacy and pharmacology. 2001, Vol 53, Num 4, pp 463-471, issn 0022-3573Article

Enhanced V-ATPase activity contributes to the improved salt tolerance of transgenic tobacco plants overexpressing vacuolar Na+/H+ antiporter AtNHX1SHUFENG ZHOU; ZHIMING ZHANG; QILIN TANG et al.Biotechnology letters. 2011, Vol 33, Num 2, pp 375-380, issn 0141-5492, 6 p.Article

Design of new oxazaphosphorine anticancer drugsJUN LIANG; MIN HUANG; WEI DUAN et al.Current pharmaceutical design. 2007, Vol 13, Num 9, pp 963-978, issn 1381-6128, 16 p.Article

Transport of thalidomide by the human intestinal Caco-2 monolayersSHUFENG ZHOU; YAN LI; KESTELL, Phillip et al.European journal of drug metabolism and pharmacokinetics. 2005, Vol 30, Num 1-2, pp 49-61, issn 0378-7966, 13 p.Article

Pharmacokinetic interactions of drugs with St John's wortSHUFENG ZHOU; CHAN, Eli; PAN, Shen-Quan et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 2, pp 262-276, issn 0269-8811, 15 p.Article

A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomideSHUFENG ZHOU; KESTELL, Philip; TINGLE, Malcolm D et al.Cancer chemotherapy and pharmacology. 2001, Vol 47, Num 6, pp 541-544, issn 0344-5704Article

Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomesSHUFENG ZHOU; CHIN, Rebecca; KESTELL, Philip et al.British journal of clinical pharmacology. 2001, Vol 52, Num 2, pp 129-136, issn 0306-5251Article

Prediction of herb-drug metabolic interactions : A simulation studySHUFENG ZHOU; MIN HUANG; ANLONG XU et al.PTR. Phytotherapy research. 2005, Vol 19, Num 6, pp 464-471, issn 0951-418X, 8 p.Article

The PKCα-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signalsYIMIN ZHU; QIHAN DONG; BEE JEN TAN et al.Cancer research (Baltimore). 2005, Vol 65, Num 11, pp 4520-4524, issn 0008-5472, 5 p.Article

Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studiesSHUFENG ZHOU; XIA FENG; KESTELL, Philip et al.Journal of chromatography. B. 2004, Vol 809, Num 1, pp 87-97, issn 1570-0232, 11 p.Article

Determination of two major metabolites of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in hepatic microsomal incubations by high-performance liquid chromatography with fluorescence detectionSHUFENG ZHOU; PAXTON, J. W; TINGLE, M. D et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 734, Num 1, pp 129-136, issn 1387-2273Article

High-throughput screening of potential inhibitors for the metabolism of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acidSHUFENG ZHOU; CHIANG, Daniel; CHIN, Rebecca et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 767, Num 1, pp 19-26, issn 1387-2273Article

In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenacSHUFENG ZHOU; PAXTON, James W; KESTELL, Philip et al.Cancer chemotherapy and pharmacology. 2001, Vol 47, Num 4, pp 319-326, issn 0344-5704Article

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsSHUFENG ZHOU; SUI YUNG CHAN; BOON CHER GOH et al.Clinical pharmacokinetics. 2005, Vol 44, Num 3, pp 279-304, issn 0312-5963, 26 p.Article

  • Page / 2